Carolyn Stoll

Carolyn Stoll

Auto-generated profile, based on publicly available information

Carolyn Stoll

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in Research Synthesis Methods
Verified
Journal Article
Closed access
PDF file
CSCarolyn R.T. Stoll
Carolyn R.T. Stoll
SISonya Izadi
Sonya Izadi
SFSusan Fowler
Susan Fowler
PGPaige Green
Paige Green
JSJerry Suls
Jerry Suls
GCGraham A Colditz
Graham A Colditz

1 September 2019 in Health Psychology
Verified
Journal Article
Closed access
CSCarolyn R. T. Stoll
Carolyn R. T. Stoll
SISonya Izadi
Sonya Izadi
SFSusan Fowler
Susan Fowler
SPSydney Philpott-Streiff
Sydney Philpott-Streiff
PGPaige Green
Paige Green
GCGraham A Colditz
Graham A Colditz
As the population with multiple chronic conditions (MCC) increases, it is essential that randomized controlled trials (RCTs) consider MCC. Behavioral interventions have the potential to positively impact MCC patient outcomes; however, a comprehensive review of consideration of MCC in these trials has not been conducted. The purpose of this systematic review is to determine the frequency with which participants with MCC are represented in behavioral intervention RCTs targeting chronic illness published 2000-2014. MEDLINE and EMBASE were searched from 2000 to 2014 to identify RCTs testing behavioral interventions among adults with chronic illness. A random sampling selection process was performed to identify 600 eligible studies representative of the literature. Two reviewers independently extracted information on consideration of MCC in eligibility criteria and evaluated the reporting and consideration of MCC in trial analyses. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. In 600 behavioral intervention RCTs, targeting MCC was rare (4.3%). Exclusion of MCC was common (68.3%) and was done through general, specific, or vague exclusion criteria. 218 (36.3%) trials reported presence of MCCs through general or condition-specific measures. Comorbidities were only considered in 4.8% of all trial analyses. In this comprehensive systematic review of 600 studies published from 2000-2014, RCTs testing behavioral interventions rarely consider individuals with MCC, limiting generalizability. Given the public health relevance and limited evidence base, this work highlights the urgent need to improve the consideration of MCC in clinical trial research. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

9 January 2020 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
JWJean F. Wyman
Jean F. Wyman
JZJincheng Zhou
Jincheng Zhou
DLD. Yvette LaCoursiere
D. Yvette LaCoursiere
AMAlayne D. Markland
Alayne D. Markland
EMElizabeth R. Mueller
Elizabeth R. Mueller
SSSiobhan Sutcliffe
Siobhan Sutcliffe

20 June 2023 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
AAAkila Anandarajah
Akila Anandarajah
YCYongzhen Chen
Yongzhen Chen
CSCarolyn Stoll
Carolyn Stoll
AHAngela Hardi
Angela Hardi
SJShu Jiang
Shu Jiang
GCGraham A Colditz
Graham A Colditz
Purpose: It may be important for women to have mammograms at different points in time to track changes in breast density, as fluctuations in breast density can affect breast cancer risk. This systematic review aimed to assess methods used to relate repeated mammographic images to breast cancer risk. Methods: The databases including Medline (Ovid) 1946-, Embase.com 1947-, CINAHL Plus 1937-, Scopus 1823-, Cochrane Library (including CENTRAL), and Clinicaltrials.gov were searched through October 2021. Eligibility criteria included published articles in English describing the relationship of change in mammographic features with risk of breast cancer. Risk of bias was assessed using the Quality in Prognostic Studies tool. Results: Twenty articles were included. The Breast Imaging Reporting and Data System and Cumulus were most commonly used for classifying mammographic density and automated assessment was used on more recent digital mammograms. Time between mammograms varied from 1 year to a median of 4.1, and only nine of the studies used more than two mammograms. Several studies showed that adding change of density or mammographic features improved model performance. Variation in risk of bias of studies was highest in prognostic factor measurement and study confounding. Conclusion: This review provided an updated overview and revealed research gaps in assessment of the use of texture features, risk prediction, and AUC. We provide recommendations for future studies using repeated measure methods for mammogram images to improve risk classification and risk prediction for women to tailor screening and prevention strategies to level of risk.

18 November 2021 in medRxiv
Verified
Preprint
Open access
PDF file
AAAkila Anandarajah
Akila Anandarajah
YCYongzhen Chen
Yongzhen Chen
GCGraham A Colditz
Graham A Colditz
AHAngela Hardi
Angela Hardi
CSCarolyn Stoll
Carolyn Stoll
SJShu Jiang
Shu Jiang
This systematic review aimed to assess the methods used to classify mammographic breast parenchymal features in relation to prediction of future breast cancer including the time from mammogram to diagnosis of breast cancer, and methods for the identification of texture features and selection of features for inclusion in analysis. The databases including Medline (Ovid) 1946-, Embase.com 1947-, CINAHL Plus 1937-, Scopus 1823-, Cochrane Library (including CENTRAL), and Clinicaltrials.gov . were searched through October 2021 to extract published articles in English describing the relationship of parenchymal texture features with risk of breast cancer. Twenty-eight articles published since 2016 were included in the final review. Of these, 7 assessed texture features from film mammograms images, 3 did not report details of the image used, and the others used full field mammograms from Hologic, GE and other manufacturers. The identification of parenchymal texture features varied from using a predefined list to machine-driven identification. Reduction in number of features chosen for analysis in relation to cancer incidence then varied across statistical approaches and machine learning methods. The variation in approach and number of features identified for inclusion in analysis precluded generating a quantitative summary or meta-analysis of the value of these to improve predicting risk of future breast cancers. This updated overview of the state of the art revealed research gaps; based on these, we provide recommendations for future studies using parenchymal features for mammogram images to make use of accumulating image data, and external validation of prediction models that extend to 5 and 10 years to guide clinical risk management. By following these recommendations, we expect to improve risk classification and risk prediction for women to tailor screening and prevention strategies to level of risk.

28 February 2026 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
AAAkila Anandarajah
Akila Anandarajah
RRRachelle Roy
Rachelle Roy
GCGrace Cross
Grace Cross
CSCarolyn Stoll
Carolyn Stoll
AHAngela Hardi
Angela Hardi
AHAshley Housten
Ashley Housten
Purpose: Personalized risk communication (PRCom) can help individuals make informed decisions about electing to undergo cancer screening based on their specific risk. In this systematic review, we examined existing risk communication strategies used in the presentation of PRCom and how they may impact screening-related cognitive and behavioral outcomes. Methods: We searched Embase.com, Ovid-Medline All, Scopus, CINAHL Complete, and CENTRAL Trials (via Cochrane Library) for randomized controlled trials addressing interventions with an element of “personalized” cancer risk communication based on the individual’s risk factors. Results: Eighteen unique studies were included. From these 18 studies, we extracted data on PRCom presentation methods and outcome measures such as knowledge and screening completion. Text was used in the majority of PRCom (56%, n = 10), followed by graphs (39%, n = 7), icon arrays (17%, n = 3), charts (17%, n = 3), graphics (17%, n = 3), and video (6%, n = 1). None of these studies included direct format comparisons. We found that knowledge of risk increased in scenarios where PRCom: 1) combined visual (e.g., videos) and text-based communication; and 2) used verbatim (4/5), rather than gist communication (2/7). Screening completion also increased for PRCom with both visual and text-based communication (3/4). However, knowledge of risk and screening completion were minimally impacted if PRCom used only text/verbal communication (1/3 for knowledge of risk, 0/2 for screening completion) or only visual aids (1/3 for knowledge of risk, 2/5 for screening completion). Conclusion: Future research examining the translation of communication strategies to screening-related cognitive and behavioral outcomes is warranted.